Publications & Articles
No Category Subject Journal Writer Publication year
35951 Oncology PD-1 inhibitors for non-small cell lung cancer patients with special i... Cancer Med 2020 10.1002/cam4.2868 안명주 2020
35950 Immunology PD-1 blockade-unresponsive human tumor-infiltrating CD8(+) T cells are... CELL MOL IMMUNOL 2020 10.1038/s41423-020-0427-6 안명주 2020
35949 Oncology Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation... J CLIN ONCOL 2020 10.1200/JCO.19.00457 안명주 2020
35948 Oncology Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Unc... J CLIN ONCOL 2020 10.1200/JCO.19.00931 안명주 2020
35947 Oncology; Respiratory System Osimertinib for Patients With Leptomeningeal Metastases Associated Wit... J THORAC ONCOL 2020 10.1016/j.jtho.2019.12.113 안명주 2020
35946 Oncology; Pharmacology & Pharmacy Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lu... INVEST NEW DRUG 2020 10.1007/s10637-019-00795-3 안명주 2020
35945 Oncology Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Pa... CANCER RES TREAT 2020 10.4143/crt.2019.186 안명주 2020
35944 Medicine, Research & Experimental Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Pa... IN VIVO 2020 10.21873/invivo.11920 안명주 2020
35943 Oncology Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lu... CANCER RES TREAT 2020 10.4143/crt.2019.200 안명주 2020
35942 Oncology TATTON: a multi-arm, phase lb trial of osimertinib combined with selum... ANN ONCOL 2020 10.1016/j.annonc.2020.01.013 안명주 2020